ERBB2 and breast carcinoma: Routine clinical evaluation and diagnosis of breast cancer is categorised into three major distinct molecular subtypes based on their hormone receptor status: estrogen receptor (ER α) and progesterone receptor (PR) positive, Herceptin 2 positive (HER2+), and triple negative (ER/PR/HER2 negative) [12–14].